FDA must warn shoppers: foods high in sugar, salt, and fat
H.R. 4725 — TRUTH in Labeling Act · Filed by Jan Schakowsky (D-IL) · 10 cosponsors · Introduced Jul 23, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires the FDA to finalize a rule mandating front-of-package warning labels on foods high in added sugars, sodium, or saturated fat—with separate "High in" labels and exclamation-point icons for each nutrient. Foods containing non-nutritive sweeteners must also carry a statement warning that these are not recommended for children. The rule must be finalized within 180 days and apply to foods marketed for infants and young children, potentially prompting food manufacturers to reformulate products to reduce these nutrients.
Why we flagged it
The bill's operative mechanism is a mandatory disclosure requirement—front-of-package labeling—designed to inform consumer choice and incentivize product reformulation toward healthier nutrient profiles. It is fundamentally a transparency and public-health measure, not a subsidy, carve-out, or deregulation.
What the text implies
- Food manufacturers may face significant reformulation costs and supply-chain disruption to comply with labeling and to reduce high-sodium, high-sugar, and high-saturated-fat products—costs that may be passed to consumers, potentially raising prices on processed foods.
- The bill's non-nutritive sweetener disclosure may inadvertently stigmatize diet products and sugar-free alternatives, potentially reducing their market share even where they represent a net health benefit for certain populations (e.g., diabetics).
- The 180-day deadline for FDA finalization is aggressive; if Daily Reference Values for infants and young children are not established in time, the rule may issue without age-specific thresholds, creating ambiguity in label application.
- Front-of-package labels may disproportionately affect smaller food manufacturers and regional brands with lower compliance budgets, potentially consolidating market share toward larger corporations with resources to reformulate quickly.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill enhances consumer transparency by requiring clear, front-of-package warnings about high levels of added sugars, sodium, and saturated fat—nutrients linked to serious chronic diseases. Research cited in the bill shows such labels improve purchasing decisions, particularly for lower-income and less-educated consumers who underuse traditional nutrition facts panels. The non-nutritive sweetener disclosure protects children from products reformulated to swap sugar for artificial sweeteners w
Who stands to gain
- Food manufacturers (reformulation and relabeling costs create consulting, packaging, and supply-chai
- Label-design and compliance consulting firms
- Nutritional reformulation service providers
Named in the bill
FDA (Food and Drug Administration), HHS (Department of Health and Human Services), USDA (Department of Agriculture), Food manufacturers (general sector), Dietary Guidelines for Americans (2020–2025), Federal Food, Drug, and Cosmetic Act
Where it stands
10 cosponsors: 10 Democrats.
- Jul 23, 2025 — Introduced · Congress.gov: “Introduced in House”
- Jul 23, 2025 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
4 lobbying clients named this bill on 5 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $290,000 in lobbying spend. A filing names 4 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 72% of bills with at least one filing.
Jan Schakowsky, the sponsor, reported $88,051 in PAC receipts in the 2026 cycle.
- Dupont De Nemours, Inc. — $130,000 on 2 filings
- Unilever United States, Inc. — $130,000 on 1 filing
- Mondelez International, Inc. — $30,000 on 1 filing
- Cspi Action Fund — $0 on 1 filing
Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (5,903 characters) on Aug 20, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Dec 2025 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 20, 2026 · page rendered 2026-10-20.
“FDA must warn shoppers: foods high in sugar, salt, and fat” QuorumCivic. https://share.quorumcivic.app/bill/119/hr4725 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.